DAily time use, Physical Activity, quality of care and interpersonal relationships in patients with Schizophrenia spectrum disorders (DiAPASon): an Italian multicentre study.
Daily time use
Experience sampling method
Schizophrenia
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
08 06 2020
08 06 2020
Historique:
received:
25
02
2020
accepted:
05
04
2020
entrez:
10
6
2020
pubmed:
10
6
2020
medline:
30
10
2020
Statut:
epublish
Résumé
Schizophrenia spectrum disorders (SSD) are ranked among the leading causes of disabilities worldwide. Many people with SSD spend most of their daily time being inactive, and this is related to the severity of negative symptoms. Here, we present the 3-year DiAPAson project aimed at (1) evaluating the daily time use among patients with SSD living in Residential Facilities (RFs) compared to outpatients with SSD and to the general population (Study 1); (2) evaluating the quality of staff-patient relationships, its association with specific patient outcomes and the quality of care provided in RFs (Study 2); and (3) assessing daily activity patterns in residential patients, outpatients with SSD and healthy controls using real-time methodologies (Study 3). Study 1 will include 300 patients with SSD living in RFs and 300 outpatients; data obtained in these clinical populations will be compared with normative data obtained by the National Institute of Statistics (ISTAT) in the national survey on daily time use. Time use assessments will consist of daily diaries asking participants to retrospectively report time spent in different activities. In Study 2, a series of questionnaires will be administered to 300 residential patients (recruited for Study 1) to evaluate the quality of care and staff-patient relationships, level of well-being and burnout of RFs' staff, and quality of RFs using a European standardized questionnaire (QuIRC-SA). In Study 3, the daily time use will be evaluated in a subgroup of 50 residential patients, 50 outpatients and 50 healthy controls using the Experience Sampling Method approach (participants will complete a brief questionnaire -about time use, mood and perceived energy- on a smartphone 8 times a day for 1 week) to compare retrospective and real-time reports. Moreover, their level of physical activity, sleep patterns, and energy expenditure will be monitored through a multi-sensor device. This project is highly innovative because it combines different types of assessments (i.e., retrospective and real-time reports; multi-sensor monitoring) to trace an accurate picture of daily time use and levels of physical activity that will help identify the best therapeutic options promoting daily activities and physical exercise in patients with SSD. ISRCTN registry ID ISRCTN21141466.
Sections du résumé
BACKGROUND
Schizophrenia spectrum disorders (SSD) are ranked among the leading causes of disabilities worldwide. Many people with SSD spend most of their daily time being inactive, and this is related to the severity of negative symptoms. Here, we present the 3-year DiAPAson project aimed at (1) evaluating the daily time use among patients with SSD living in Residential Facilities (RFs) compared to outpatients with SSD and to the general population (Study 1); (2) evaluating the quality of staff-patient relationships, its association with specific patient outcomes and the quality of care provided in RFs (Study 2); and (3) assessing daily activity patterns in residential patients, outpatients with SSD and healthy controls using real-time methodologies (Study 3).
METHODS
Study 1 will include 300 patients with SSD living in RFs and 300 outpatients; data obtained in these clinical populations will be compared with normative data obtained by the National Institute of Statistics (ISTAT) in the national survey on daily time use. Time use assessments will consist of daily diaries asking participants to retrospectively report time spent in different activities. In Study 2, a series of questionnaires will be administered to 300 residential patients (recruited for Study 1) to evaluate the quality of care and staff-patient relationships, level of well-being and burnout of RFs' staff, and quality of RFs using a European standardized questionnaire (QuIRC-SA). In Study 3, the daily time use will be evaluated in a subgroup of 50 residential patients, 50 outpatients and 50 healthy controls using the Experience Sampling Method approach (participants will complete a brief questionnaire -about time use, mood and perceived energy- on a smartphone 8 times a day for 1 week) to compare retrospective and real-time reports. Moreover, their level of physical activity, sleep patterns, and energy expenditure will be monitored through a multi-sensor device.
DISCUSSION
This project is highly innovative because it combines different types of assessments (i.e., retrospective and real-time reports; multi-sensor monitoring) to trace an accurate picture of daily time use and levels of physical activity that will help identify the best therapeutic options promoting daily activities and physical exercise in patients with SSD.
TRIAL REGISTRATION
ISRCTN registry ID ISRCTN21141466.
Identifiants
pubmed: 32513140
doi: 10.1186/s12888-020-02588-y
pii: 10.1186/s12888-020-02588-y
pmc: PMC7278132
doi:
Banques de données
ISRCTN
['ISRCTN21141466']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
287Subventions
Organisme : Ministero della Salute
ID : RF-2018-12365514
Pays : International
Références
World Psychiatry. 2017 Oct;16(3):308-315
pubmed: 28941119
Ann Intern Med. 2015 Jan 20;162(2):123-32
pubmed: 25599350
Schizophr Res. 2014 Oct;159(1):144-50
pubmed: 25182540
Soc Psychiatry Psychiatr Epidemiol. 2014 Jan;49(1):157-67
pubmed: 23712514
Asian J Psychiatr. 2019 Dec;46:62-67
pubmed: 31627166
Epidemiol Psichiatr Soc. 2000 Jan-Mar;9(1):45-55
pubmed: 10859875
Med Sci Sports Exerc. 2004 May;36(5):897-904
pubmed: 15126727
J Abnorm Psychol. 1968 Dec;73(6):595-604
pubmed: 5717365
Am J Psychiatry. 1999 Sep;156(9):1358-66
pubmed: 10484945
PLoS One. 2012;7(6):e38070
pubmed: 22675508
Psychol Med. 1998 May;28(3):551-8
pubmed: 9626712
Lancet Psychiatry. 2019 Aug;6(8):675-712
pubmed: 31324560
CMAJ. 2006 Mar 14;174(6):801-9
pubmed: 16534088
Psychotherapy (Chic). 2011 Dec;48(4):359-67
pubmed: 21604904
Schizophr Res. 2015 Feb;161(2-3):188-93
pubmed: 25541138
Community Ment Health J. 1990 Apr;26(2):193-204
pubmed: 2354615
Eur Psychiatry. 2015 Jul;30(5):641-7
pubmed: 25758156
Epidemiol Rev. 2008;30:67-76
pubmed: 18480098
Schizophr Bull. 2015 Jul;41(4):869-78
pubmed: 25829377
Med Sci Sports Exerc. 2004 Jun;36(6):1063-9
pubmed: 15179178
Psychiatr Rehabil J. 2012 Dec;35(6):447-53
pubmed: 23276238
Br J Psychiatry. 1995 Nov;167(5):589-95
pubmed: 8564313
Schizophr Bull. 2000;26(4):847-54
pubmed: 11087017
J Am Acad Psychiatry Law. 2014;42(2):173-81
pubmed: 24986344
Eur Psychiatry. 2018 Sep;53:74-99
pubmed: 29957371
Schizophr Bull. 2014 Nov;40(6):1244-53
pubmed: 24609454
Compr Psychiatry. 2015 Jan;56:133-40
pubmed: 25308404
Br J Clin Psychol. 2011 Mar;50(1):84-105
pubmed: 21332522
Psychopathology. 2009;42(3):185-9
pubmed: 19325255
BMC Psychiatry. 2009 Sep 07;9:55
pubmed: 19735562
Br Med J. 1970 May 23;1(5707):439-43
pubmed: 5420206
J Sport Exerc Psychol. 2010 Apr;32(2):253-61
pubmed: 20479481
Schizophr Bull. 2011 Mar;37(2):244-7
pubmed: 21224492
Psychol Med. 1985 May;15(2):411-5
pubmed: 4023145
Prev Med. 2009 Feb;48(2):151-5
pubmed: 19046984
Epidemiol Psychiatr Sci. 2018 Oct;27(5):519-527
pubmed: 28580898
Soc Work Res Abstr. 1983 Fall;19(3):9-21
pubmed: 10264257
BMC Psychiatry. 2016 Apr 14;16:101
pubmed: 27075574
Schizophr Bull. 2017 May 1;43(3):546-556
pubmed: 27521348
Int J Soc Psychiatry. 2004 Jun;50(2):115-28
pubmed: 15293429
Int J Cardiol. 2014 May 15;173(3):588-90
pubmed: 24698235
Schizophr Bull. 2018 Oct 17;44(6):1195-1203
pubmed: 29762765
Can J Psychiatry. 2007 Nov;52(11):693-701
pubmed: 18399036
Psychol Assess. 2012 Sep;24(3):701-12
pubmed: 22250591
J Med Internet Res. 2019 May 15;21(5):e11967
pubmed: 31094349
Schizophr Res. 2012 Dec;142(1-3):88-92
pubmed: 23127378
Schizophr Bull. 2016 May;42(3):588-99
pubmed: 26547223
Schizophr Bull. 2020 Feb 26;46(2):242-251
pubmed: 31504955
Lancet Psychiatry. 2016 Dec;3(12):1129-1137
pubmed: 27771286
Psychol Med. 1993 May;23(2):511-23
pubmed: 8332665
Disabil Rehabil. 2009;31(7):553-64
pubmed: 19191060
Schizophr Res. 2011 Oct;132(1):24-7
pubmed: 21771567
JAMA Psychiatry. 2019 Feb 1;76(2):190-198
pubmed: 30540352
BMC Psychiatry. 2019 Dec 19;19(1):410
pubmed: 31856767
J Pers Disord. 2019 Oct 14;:1-19
pubmed: 31609185
Schizophr Res. 2016 Oct;176(2-3):480-484
pubmed: 27422333
Psychiatry Res. 2015 Oct 30;229(3):828-39
pubmed: 26254795
BMJ Open. 2012 Oct 08;2(5):
pubmed: 23045359
Schizophr Res. 2017 May;183:49-55
pubmed: 27881233
Eur Neuropsychopharmacol. 2013 Jul;23(7):675-85
pubmed: 22981376
Schizophr Res. 2016 Oct;176(2-3):431-440
pubmed: 27261419
Eur Psychiatry. 2009 Jan;24(1):41-6
pubmed: 18835138
BMC Public Health. 2019 Jun 3;19(Suppl 2):607
pubmed: 31159790
World Psychiatry. 2015 Oct;14(3):339-47
pubmed: 26407790
Epidemiol Psichiatr Soc. 1999 Apr-Jun;8(2):135-67
pubmed: 10617372
BMC Public Health. 2019 Jun 3;19(Suppl 2):455
pubmed: 31159770
Annu Rev Clin Psychol. 2008;4:1-32
pubmed: 18509902
Psychol Med. 2005 Mar;35(3):421-31
pubmed: 15841877
Psychol Psychother. 2004 Jun;77(Pt 2):255-72
pubmed: 15193196